Hershey Trust CO Natera, Inc. Transaction History

Hershey Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$26.36 - $49.86 $207,901 - $393,245	-7,887 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$17.27 - $40.17 $136,173 - $316,740	-7,885 Reduced 49.99%	7,887 $236,000
Q4 2019 Jan 28, 2020	BUY	$32.1 - $40.4 $316,441 - $398,263	9,858 Added 166.69%	15,772 $531,000
Q3 2019 Oct 31, 2019	BUY	$25.38 - $34.89 $150,097 - $206,339	5,914 New	5,914 $194,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.